AI-powered platform discovering bioactive peptides from plants.
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Series C Irish biotech Nuritas raised $42m in Series C to scale its AI peptide-discovery platform. | $42M |
| Nov 2021 | Series B Dublin biotech Nuritas raised a USD 45M Series B led by Cleveland Avenue to scale its AI peptide-discovery platform. | $45M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.